VEGFA and autoimmune disease: Additionally, it highlights the value for the development of inhibitors targeting hypoxia‐inducible factor 1 and 2 in TAMs.35 Further investigation is needed to examine whether PD‐L1+ M2 macrophages stimulated by autocrine VEGF can be potent for immunotherapy of autoimmune diseases.